These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 31026023)

  • 41. Transfer learning with convolutional neural networks for cancer survival prediction using gene-expression data.
    López-García G; Jerez JM; Franco L; Veredas FJ
    PLoS One; 2020; 15(3):e0230536. PubMed ID: 32214348
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The importance of FISH signal cut-off values for 9p21 deletion in malignant pleural mesothelioma: Is it underestimated?
    Kulduk G; Ekinci Ö; Toker G; Demirci U; Özaydın E; Akyürek N; Memiş L
    Pathol Res Pract; 2019 Jun; 215(6):152377. PubMed ID: 30885529
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Integrative analysis identifies potential DNA methylation biomarkers for pan-cancer diagnosis and prognosis.
    Ding W; Chen G; Shi T
    Epigenetics; 2019 Jan; 14(1):67-80. PubMed ID: 30696380
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Sarcomatoid malignant mesothelioma: a clinicopathologic and immunohistochemical analysis of 22 cases].
    Lao I; Chen Q; Yu L; Wang J
    Zhonghua Bing Li Xue Za Zhi; 2014 Jun; 43(6):364-9. PubMed ID: 25208984
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.
    Beltran H; Eng K; Mosquera JM; Sigaras A; Romanel A; Rennert H; Kossai M; Pauli C; Faltas B; Fontugne J; Park K; Banfelder J; Prandi D; Madhukar N; Zhang T; Padilla J; Greco N; McNary TJ; Herrscher E; Wilkes D; MacDonald TY; Xue H; Vacic V; Emde AK; Oschwald D; Tan AY; Chen Z; Collins C; Gleave ME; Wang Y; Chakravarty D; Schiffman M; Kim R; Campagne F; Robinson BD; Nanus DM; Tagawa ST; Xiang JZ; Smogorzewska A; Demichelis F; Rickman DS; Sboner A; Elemento O; Rubin MA
    JAMA Oncol; 2015 Jul; 1(4):466-74. PubMed ID: 26181256
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Application of Transcriptome-Based Gene Set Featurization for Machine Learning Model to Predict the Origin of Metastatic Cancer.
    Jeong Y; Chu J; Kang J; Baek S; Lee JH; Jung DS; Kim WW; Kim YR; Kang J; Do IG
    Curr Issues Mol Biol; 2024 Jul; 46(7):7291-7302. PubMed ID: 39057073
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Secreted and Tissue miRNAs as Diagnosis Biomarkers of Malignant Pleural Mesothelioma.
    Martínez-Rivera V; Negrete-García MC; Ávila-Moreno F; Ortiz-Quintero B
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29462963
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pan-Cancer Molecular Classes Transcending Tumor Lineage Across 32 Cancer Types, Multiple Data Platforms, and over 10,000 Cases.
    Chen F; Zhang Y; Gibbons DL; Deneen B; Kwiatkowski DJ; Ittmann M; Creighton CJ
    Clin Cancer Res; 2018 May; 24(9):2182-2193. PubMed ID: 29440175
    [No Abstract]   [Full Text] [Related]  

  • 49. Sarcomatoid mesothelioma and its histological mimics: a comparative immunohistochemical study.
    Lucas DR; Pass HI; Madan SK; Adsay NV; Wali A; Tabaczka P; Lonardo F
    Histopathology; 2003 Mar; 42(3):270-9. PubMed ID: 12605647
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MUC4 immunohistochemistry is useful in distinguishing epithelioid mesothelioma from adenocarcinoma and squamous cell carcinoma of the lung.
    Mawas AS; Amatya VJ; Kushitani K; Kai Y; Miyata Y; Okada M; Takeshima Y
    Sci Rep; 2018 Jan; 8(1):134. PubMed ID: 29317712
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Metastasis revealing malignant peritoneum mesothelioma: About the difficulty to identify the primary tumors].
    Bretagne CH; Petitjean A; Felix S; Bedgedjian I; Algros MP; Delabrousse E; Valmary-Degano S;
    Ann Pathol; 2016 Apr; 36(2):105-10. PubMed ID: 26993587
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tumor-specific genetic variants can be detected in circulating cell-free DNA of malignant pleural mesothelioma patients.
    Hylebos M; Op de Beeck K; Pauwels P; Zwaenepoel K; van Meerbeeck JP; Van Camp G
    Lung Cancer; 2018 Oct; 124():19-22. PubMed ID: 30268460
    [TBL] [Abstract][Full Text] [Related]  

  • 53. DNA methylation markers for diagnosis and prognosis of common cancers.
    Hao X; Luo H; Krawczyk M; Wei W; Wang W; Wang J; Flagg K; Hou J; Zhang H; Yi S; Jafari M; Lin D; Chung C; Caughey BA; Li G; Dhar D; Shi W; Zheng L; Hou R; Zhu J; Zhao L; Fu X; Zhang E; Zhang C; Zhu JK; Karin M; Xu RH; Zhang K
    Proc Natl Acad Sci U S A; 2017 Jul; 114(28):7414-7419. PubMed ID: 28652331
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Minimalist approaches to cancer tissue-of-origin classification by DNA methylation.
    Xia D; Leon AJ; Cabanero M; Pugh TJ; Tsao MS; Rath P; Siu LL; Yu C; Bedard PL; Shepherd FA; Zadeh G; Chetty R; Aldape K
    Mod Pathol; 2020 Oct; 33(10):1874-1888. PubMed ID: 32415265
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adaptation of a commercial fluorescent in situ hybridization test to the diagnosis of malignant cells in effusions.
    Flores-Staino C; Darai-Ramqvist E; Dobra K; Hjerpe A
    Lung Cancer; 2010 Apr; 68(1):39-43. PubMed ID: 19523712
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An integrated tool for determining the primary origin site of metastatic tumours.
    Santos MTD; Souza BF; Cárcano FM; Vidal RO; Scapulatempo-Neto C; Viana CR; Carvalho AL
    J Clin Pathol; 2018 Jul; 71(7):584-593. PubMed ID: 29248889
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification and transfer of spatial transcriptomics signatures for cancer diagnosis.
    Yoosuf N; Navarro JF; Salmén F; Ståhl PL; Daub CO
    Breast Cancer Res; 2020 Jan; 22(1):6. PubMed ID: 31931856
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of ALK Rearrangements in Malignant Peritoneal Mesothelioma.
    Hung YP; Dong F; Watkins JC; Nardi V; Bueno R; Dal Cin P; Godleski JJ; Crum CP; Chirieac LR
    JAMA Oncol; 2018 Feb; 4(2):235-238. PubMed ID: 28910456
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer.
    Li B; Cui Y; Diehn M; Li R
    JAMA Oncol; 2017 Nov; 3(11):1529-1537. PubMed ID: 28687838
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of Tissue of Origin and Guided Therapeutic Applications in Cancers of Unknown Primary Using Deep Learning and RNA Sequencing (TransCUPtomics).
    Vibert J; Pierron G; Benoist C; Gruel N; Guillemot D; Vincent-Salomon A; Le Tourneau C; Livartowski A; Mariani O; Baulande S; Bidard FC; Delattre O; Waterfall JJ; Watson S
    J Mol Diagn; 2021 Oct; 23(10):1380-1392. PubMed ID: 34325056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.